Hypertension: a policy perspective, 1976–2008
- 30 April 2009
- journal article
- review article
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 3 (2) , 113-118
- https://doi.org/10.1016/j.jash.2008.12.001
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Journal of General Internal Medicine, 2008
- Heart Disease and Stroke Statistics—2008 UpdateCirculation, 2008
- Economic Implications of Evidence-Based Prescribing for HypertensionJAMA, 2004
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost‐effectiveness of intensive blood pressure lowering and low‐dose aspirin in patients with hypertensionJournal of Internal Medicine, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 DiabetesJAMA, 2002
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Allocation of Resources to Manage HypertensionNew England Journal of Medicine, 1977
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977